ANTHEM BIOSCIENCES
Back to Cashflow Statement
|
ANTHEM BIOSCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-40 Cr | ₹-136 Cr | ₹-77 Cr | ₹64 Cr | ₹181 Cr |
What is the latest Cash Flow from Financing Activities ratio of ANTHEM BIOSCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-40 Cr |
| Mar2025 | ₹-136 Cr |
| Mar2024 | ₹-77 Cr |
| Mar2023 | ₹64 Cr |
| Mar2022 | ₹181 Cr |
How is Cash Flow from Financing Activities of ANTHEM BIOSCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-40 Cr | Negative | |
| Mar2025 | ₹-136 Cr | Negative | |
| Mar2024 | ₹-77 Cr | Negative | |
| Mar2023 | ₹64 Cr | -64.59 | |
| Mar2022 | ₹181 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ANTHEM BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANTHEM BIOSCIENCES | ₹43,852.2 Cr | 2.6% | 1.6% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
ANTHEM BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANTHEM BIOSCIENCES | 2.6% |
1.6% |
|
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses